Numerous immature thymocytes undergo apoptosis and are rapidly engulfed by phagocytic thymic macrophages. The macrophage surface receptors involved in apoptotic thymocyte recognition are unknown. We have examined the role of the class A macrophage scavenger receptor (SR-A) in the engulfmnent of apoptotic thymocytes. Uptake of steroid-treated apoptotic thymocytes by thymic and inflammatory-elicited SR-A positive macrophages is partially inhibited by an anti-SR-A mAb and more completely by a range of scavenger receptor ligands. Thymic macrophages from mice with targeted disruption of the SR-A gene show a 50% reduction in phagocytosis of apoptotic thymocytes in vitro. These data suggest that SR-A may play a role in the clearance of dying cells in the thymus.
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Apoptosis or programmed cell death is now recognized as the physiologic mechanism by which large numbers of unwanted cells are deleted from the body (1) . However, examination of tissues with ongoing programmed cell death highlights the scant evidence of dying cells in situ, a paradox that is explained by the existence of mechanisms for the specific and rapid removal of apoptotic cells by phagocytes. One of the earliest markers of commitment to undergo programmed cell death is phagocytosis of the apoptotic cell. In contrast to our knowledge of the process of apoptosis itself, relatively little is known of the clearance process by which dying cells are removed from the body in a manner that has no apparent inflammatory consequence. Examination of apoptotic cells in situ has shown that they are taken up and degraded by phagocytes, in particular macrophages (M+) (2) . This activity can be observed in MO-like cells from species such as Drosophila, suggesting this is an important and conserved process (3) The process is specific, in that only cells committed to die are phagocytosed, and rapid, so that uptake is completed before the integrity of the apoptotic cell membrane is lost. Two essential components are required for the successful ingestion of the apoptotic cells: (i) specific receptor(s) on the surface of the phagocyte to mediate rapid recognition and ingestion and (ii) the presence of appropriate ligands on apoptotic cells that permit their distinction from healthy neighbors. The consensus that can be drawn from the relatively small number of reported studies on apoptotic cell recognition is that just like the regulation of apoptosis itself, it is complex and that there is not a single receptor-ligand system that explains apoptotic cell removal by all phagocytes (4) .
The thymus is the organ where the repertoire of mature T cells is selected from a much larger number of immature thymocytes and extensive apoptotic cell death occurs in the immature thymocyte populations. Although numerous immature thymocytes undergo apoptosis (5-7), few dead cells are observed in situ due to rapid engulfment by phagocytic M4 in the thymic stroma (8) (9) (10) . A recent study (11) , using the sensitive terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) technique to examine the spatial distribution of apoptotic thymocytes, found that the majority of immature thymocytes die in the cortical region of the thymus and that all, the detectable dead cells are localized within thymic M+. This confirmed that thymic MO are the principal stromal cells responsible for the phagocytosis of dying thymocytes and that the uptake is rapid, because it was rare to find "free" or uningested apoptotic thymocytes. While surface receptors of MO have been implicated in recognition of other apoptotic cells (4), receptors for apoptotic thymocytes are currently ill-defined (4). With particular relevance to this study, Sambrano and coworkers (12, 13) have shown that a receptor on peritoneal MO (PM) for oxidized low density lipoprotein (LDL) can mediate the binding of both oxidatively damaged red cells and apoptotic thymocytes in vitro. An analogous relationship has been reported for CD36, which is also a receptor for oxidized LDL (14) and recognizes apoptotic neutrophils (4). (15) (16) (17) . However, it is not known whether SR-A can act as a phagocytic receptor. Recently we isolated a specific rat mAb (2F8) that inhibited divalent cation-independent adhesion of MO in vitro, immunoprecipitated type I and II SR-A from MO (17) , and have demonstrated specific antigen expression by MO in different tissues (18 tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. isotype-matched control (22) (25 ,ug/ml-'), anti-CR3 mAb 5C6 (20 pug/ml-1), anti-vitronectin receptor mAb 2C11 (20 gg/ml-'; PharMingen), poly(G) (50 gg/ml-1; Pharmacia), poly(C) (50 ,ug/ml-1; Pharmacia), poly(A) (50 ,ug/ml-1; Pharmacia), dextran sulfate (100 pug/ml-1; Sigma), chondroitin sulfate (100 Ag/ml-1; Sigma), carrageenan (Sigma, 100 ,mg/ ml-'), polyvinyl sulfate (50 gg/ml-1; Sigma), fucoidan (100 ,tg/ml-1; Sigma), BSA (100 gg/ml-1; Boehringer Mannheim), and maleylated BSA (29) (100 gg/ml-), overlaid with a 30-fold excess of fluorescent apoptotic thymocytes and incubated at 37°C for 90 min. Nonphagocytosed thymocytes were removed by washing with PBS. Coverslips were examined by fluorescence microscopy and the percentage of MO that had phagocytosed labeled thymocytes scored. A minimum of 200 cells were counted in random fields from at least two independent coverslips. Comparable data were obtained in three or more independent experiments. Data are expressed as mean ± SD. TPM were also plated on coverslips coated with either BSA or maleylated BSA (29) , cultured, and assayed as above.
Immunocytochemistry. Immunostaining of thymic MO with 2F8 mAb was performed as described in ref. 18 .
RESULTS AND DISCUSSION
Thymic MO were isolated with minimal contamination by other stromal cell types, such as epithelia, by collagenase digestion, and by adherence to glass coverslips. Clusters of thymic MO with bound immature, nonapoptotic thymocytes were recovered (Fig. la) . These MO expressed 2F8 (Fig. lb) , class II MHC, macrosialin (19) , and F4/80 (20) strongly, but were weakly positive or negative for sialoadhesin (21) lipophilic dye PKH2 did not promote uptake by M+. In contrast, a50% of thymic MO incubated with steroid-treated thymocytes (>70% apoptotic, >90% viable), showed evidence of ingestion (Fig. 2 Ab and B) and this was reduced -50% by saturating concentrations of intact 2F8 mAb ( Fig. 2Ac and B) . It is of interest that a comparable degree of inhibition was observed when 2F8 was used to block endocytic uptake of diI-labeled acetylated LDL by RAW MO (14) . Rosetting of steroid treated thymocytes to thymic M4 was not apparently Proc. Natl. Acad. Sci. USA 93 (1996) 12459 fucoidan also greatly inhibited phagocytosis of apoptotic thymocytes (Fig. 2 A e and f and B) , whereas the structurally related non-SR-A ligand polycytidylic acid and an isotypematched control mAb were without effect ( Fig. 2 Ad and B) .
MO incubated in the presence of both polycytidilic acid and a ribonuclease inhibitor as a precaution against ribonucleotide degradation, also showed no effect on thymocyte uptake (not shown). The fact that the SR-A ligands inhibit to a greater extent than the 2F8 mAb suggests that other thymic MO receptors, to which these molecules may also bind, could be involved in the phagocytosis of apoptotic thymocytes.
TPM that phagocytose apoptotic lymphocytes in vitro (26) express SR-A (18) and are readily available in high yield were used to test a broader range of known SR-A ligands (25) . TPM were treated with potential inhibitors, incubated with labeled apoptotic thymocytes, and dye uptake was examined after 90 min. Under these conditions, -50% of the TPM engulf thymocytes (Fig. 3Aa and B) . Preincubation with 2F8 reduced uptake by 50%, comparable inhibition to that observed in thymic MO (Fig. 3 Ad and B) , whereas an isotype-matched control mAb (CP) and anti-type 3 complement receptor mAb (5C6) were ineffective (Fig. 3B) . A mAb (2C11) specific for the vitronectin receptor, known to mediate uptake of apoptotic neutrophils by MO (27) , did not reduce uptake, consistent with a previous study (28) that vitronectin receptor is not involved in clearance of dying lymphocytes by TPM.
Because TPM that had been incubated with 2F8 showed greatly reduced ingestion of thymocytes, we confirmed the involvement of SR-A by testing two additional classes of molecules that competitively bind to SR-A and related compounds that do not (15) . Although the degree of inhibition varied with the ligand (range 60-90%, Fig. 3B ), all the known SR-A ligands (polyguanylic acid, polyinosinic acid, maleylated BSA, fucoidan, carrageenan, dextran sulfate, and polyvinyl sulfate) reduced uptake, whereas all those that are not ligands (polyadenylic acid, polycytidilic acid, BSA, and chondroitin sulfate) were without effect. SR-A are known to bind to polyribonucleotides, polysaccharides, and modified proteins, whereas class B scavenger receptors are reported to be only inhibited by modified proteins (15) (Fig. 3B) . Cultivation on native BSA had no effect on either activity (Fig. 3B) .
To mice, which have no discernible 2F8 immunoreactivity (Fig.  4A4d) , showed a 50% reduction in their ability to phagocytoselabeled apoptotic thymocyted relative to controls (Fig. 4 Ab and B). This degree of inhibition is comparable to that seen with the 2F8 mAb (Fig. 4B) , demonstrating that this receptor accounts for -50% of the phagocytic activity required for the uptake of apoptotic thymocytes in vitro. When thymic MO are prepared from SR-A-deficient mice, they are recovered rosetted with immature, apparently healthy thymocytes, confirming that SR-A is not required for the binding of nonapoptotic thymocytes (not shown).
These data provide the first evidence for the involvement of a known receptor, SR-A, in the clearance of apoptotic thymocytes. The residual phagocytic activity of these thymic MO suggest that at least one or more additional receptors are involved in this process that are partially sensitive to SR-A anionic ligands. In addition, there is also the possibility of heterogeneity in the ligands expressed by apoptotic thymocytes. The contribution of these additional MO receptors may account for the lack of a grossly altered thymic phenotype observed in a preliminary examination of the mutant mice (data not shown). We have not yet established if SR-A functions in the removal of other dying or damaged cells. A recent study has implicated a receptor for oxidized LDL in the recognition of oxidatively damaged erythrocytes by PM (31), but preincubation with 2F8 did not reduce binding, suggesting SR-A was not involved in this system. It is also of interest that the class B scavenger receptor CD36, can convey the capacity for enhanced phagocytosis of apoptotic cells when transfected into a deficient cell type (32). This receptor is not recognized by 2F8 (17) or apparently inhibited by the full range of polyanions used in this study (15) and would therefore not appear to be involved, but the relative nonspecificity of these inhibitory ligands does not exclude the possibility that it contributes to the residual SR-A-independent uptake. Recently, a new category of scavenger receptor, class C, that has different ligand specificities, has been isolated from Drosophila and shown to be expressed in MO-like cells that contained apoptotic bodies (33). As yet there are no data to support the existence or function for vertebrate homologs of this molecule, but they are candidate phagocytic receptors that deserve consideration. Importantly our evidence presented here shows that SR-A is essential for full phagocytic activity for which other receptor(s) cannot compensate in vitro. Further studies are required to identify the additional receptor(s) required for apoptotic cell clearance in the thymus, the nature of the ligands and consequences of SR-A-mediated phagocytosis of apoptotic thymocytes by thymic Mo.
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